Parkinson’s Disease: Seeing Disease Modification

Despite decades of research and promising biological targets, disease-modifying therapies for Parkinson’s disease (PD) remain elusive. In this webinar, industry experts will explore the biology driving disease progression, the latest advances in imaging and biomarker development, and how these tools are enabling us to envision what a biomarker-driven future may look like.

You will gain insight into:

• Opportunities and challenges of assessing and monitoring PD
• Biological mechanisms and imaging approaches shaping the next generation of PD studies
• Clinical trial strategies that may pave the way toward meaningful disease modification